驱动子SVM:通过整合患者特异性和全球驱动基因来进行癌症亚型分类的机器学习方法
Junrong Song1, Yuanli Gong2, Zhiming Song3,4
1School of Information, Yunnan University of Finance and Economics, Kunming, 650221, Yunnan, People's Republic of China. zz2144@ynufe.edu.cn.
BMC bioinformatics
|December 30, 2025
概括
DriverSub-SVM通过整合患者特异性和队列范围的驱动基因数据,准确地分类癌症分子亚型. 这种新的框架通过捕捉个人异质性和共享的分子模式来改善个性化瘤学.
科学领域:
- 基因组学就是基因组学.
- 计算生物学 计算生物学
- 癌症研究 癌症研究
背景情况:
- 癌症的复杂性和异质性挑战了个性化治疗.
- 准确的分子亚型分类对于向治疗至关重要.
- 现有的方法难以捕捉患者间异质性和共享的驱动基因模式.
研究的目的:
- 开发一种可解释的癌症亚型分类的新框架.
- 整合患者特异性和队列范围的驱动基因信息.
- 为了解决捕获个人和人口层面分子模式的局限性.
主要方法:
- 在功能互动网络上使用随机走路模拟的基因影响.
- 通过贝叶斯个性化排名 (BPR) 推断出个性化驱动基因排名.
- 将排名汇总成一个共识集,并使用一对一多类支持矢量机 (OAO-MSVM) 进行分类.
主要成果:
- 在TCGA数据集上,DriverSub-SVM实现了比四种最先进的方法更高的准确性.
- 确定了与预后相关的临床相关基因.
- 发现与治疗反应相关的基因.
结论:
- 驱动器Sub-SVM为癌症亚型分类提供了一种有效的,可解释的方法.
- 该框架弥合了个人异质性和人口层面的模式.
- 对精确瘤学和生物标志物发现有前途.
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
02:18Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K